Abstract
Hypothalamic glucose sensing enables an organism to match energy expenditure and food intake to circulating levels of glucose, the main energy source of the brain. Here, we established that tanycytes of the arcuate nucleus of the hypothalamus, specialized glia that line the wall of the third ventricle, convert brain glucose supplies into lactate that they transmit through monocarboxylate transporters to arcuate proopiomelanocortin neurons, which integrate this signal to drive their activity and to adapt the metabolic response to meet physiological demands. Furthermore, this transmission required the formation of extensive connexin-43 gap junction–mediated metabolic networks by arcuate tanycytes. Selective suppression of either tanycytic monocarboxylate transporters or gap junctions resulted in altered feeding behavior and energy metabolism. Tanycytic intercellular communication and lactate production are thus integral to the mechanism by which hypothalamic neurons that regulate energy and glucose homeostasis efficiently perceive alterations in systemic glucose levels as a function of the physiological state of the organism.
Keywords: Metabolism, Neuroscience
Keywords: Glucose metabolism, Homeostasis
Introduction
Glucose plays a dual role in the brain: it is both an essential fuel that sustains brain activity and an indicator of peripheral energy status. Circulating glucose levels fluctuate as a function of food intake or energy expenditure. However, the entrance of glucose into the brain is regulated by specific transport systems (1, 2) that ensure that extracellular glucose concentrations in the brain (~2 mM), while significantly lower than those in the blood (~5 mM), remain constant to fulfill the energy needs of brain cells, regardless of the physiological state of the individual (3). How then do brain networks whose function it is to maintain energy homeostasis by modulating metabolic pathways detect changes in peripheral energy status? The arcuate nucleus of the hypothalamus (ARH), which flanks the third ventricle (3V) on both sides, contains discrete populations of neurons that are critically involved in the regulation of energy homeostasis (4, 5). Among them, the pro-opiomelanocortin (POMC) neurons (6, 7), which are electrically excited by glucose, are well placed to adjust food intake and energy expenditure in response to changes in circulating glucose levels (8). However, whether POMC neurons are themselves capable of sensing glucose remains controversial (9, 10). Instead, it seems logical for this role to be assumed by a different class of cells that is in touch, on the one hand, with both the blood and the cerebrospinal fluid (CSF), whose glucose concentrations vary in proportion to blood concentrations (11, 12) and, on the other hand, with POMC neurons, and that can therefore transmit changes in glucose levels in these 2 compartments or translate them into a signal that the neurons can perceive.
Here, we tested the hypothesis that POMC neuronal activity is not directly controlled by glucose but by its metabolite lactate (13), and we asked whether tanycytes, peculiar glial cells constituting a CSF-brain barrier along the wall of the 3V that replaces the traditional blood-brain barrier (14, 15), act as the source of the metabolic signal required by POMC neurons for hypothalamic glucose sensing and the control of energy homeostasis.
Results
POMC neurons use lactate and not glucose as an energy substrate.
Many glucose-sensing neurons respond to or integrate signals from glucose metabolites, especially lactate (10). To determine whether POMC neurons also use lactate as an energy substrate, we used whole-cell current-clamp recordings in acute brain slices from tdTomatoPOMC mice (Figure 1A). In the presence of physiological levels of glucose (2.5 mM), POMC neurons exhibited tonic firing. However, the bath application of a selective inhibitor of the monocarboxylate transporters (MCTs), α-cyano-4-hydroxycinnamate (4-CIN, 500 μM), to block lactate influx into cells (16) completely inhibited this tonic firing (P = 0.0078, Wilcoxon matched-pairs test, n = 8 cells, n = 5 mice; Figure 1, B and C), indicating that lactate, and not glucose, was fueling POMC neuronal activity. We next induced glucose deprivation by switching from 2.5 mM to 0 mM glucose in artificial cerebrospinal fluid (ACSF), which caused a marked decrease in POMC neuron firing (P = 0.0015, 1-way, repeated-measures ANOVA followed by Tukey’s post hoc test, n = 6 cells, n = 4 mice). The bath application of 5 mM lactate (equicaloric to 2.5 mM glucose; ref. 16) restored the spontaneous firing frequency of glucose-deprived POMC neurons (P = 0.0280, n = 6 cells, n = 4 mice; Figure 1, D and E). This rescue effect was in turn abolished by the bath application of 10 mM oxamate (P = 0.0277 , 1-way repeated-measures ANOVA followed by Tukey’s post hoc test, n = 7 cells, n = 5 mice; Figure 1, F–I), which inhibits lactate dehydrogenase (LDH), an enzyme responsible for the conversion of lactate to pyruvate, the metabolite that principally fuels neurons through its entry into the tricarboxylic acid cycle (17). In accordance with this sequence of events, although the addition of lactate did not compensate for the loss of neuronal activity induced by oxamate (P = 0.7811, 1-way, repeated-measures ANOVA followed by Tukey’s post hoc test, n = 5 cells, n = 4 mice; Figure 1, F and G), the bath application of pyruvate completely reversed it (5 mM) (P = 0.046, 1-way, repeated-measures ANOVA followed by Tukey’s post hoc test, n = 7 cells, n = 5 mice; Figure 1, H and I). To ascertain that changes in POMC neuronal activity were not due to an indirect action of oxamate on neighboring neurons, oxamate was directly delivered into the cytoplasm of the recorded cell via the patch pipette (Figure 1J). This cell-restricted LDH inhibition also blunted neuronal activity (P = 0.0236, 1-way repeated-measures ANOVA followed by Tukey’s post hoc test, n = 7 cells, n = 5 mice) in a pyruvate-reversible manner (P = 0.0145, n = 7 cells, n = 5 mice; Figure 1, J and K). Altogether, these results suggest that rather than glucose, lactate produced locally from glucose in living brain slices is taken up by POMC neurons via MCTs and sustains their neuronal activity through its conversion to pyruvate.
Tanycytes shuttle lactate to POMC neurons.
ARH tanycytes, thanks to the position of their cell bodies lining the walls of the 3V and end-feet that contact vessels of the blood-brain barrier (14), are in contact with both blood-borne and CSF-borne glucose and also express glucose-sensing machinery reminiscent of that found in pancreatic β cells (18–20). In addition, tanycytes express functional MCTs (21, 22). To determine whether tanycytes, rather than the astrocytic lactate shuttle that feeds neuronal activity in other brain areas (23, 24), could be the source of the endogenous lactate required by POMC neurons, we first performed experiments in primary cultures of tanycytes, which we have extensively characterized previously (25, 26). Immunofluorescence experiments showed that cultured tanycytes expressed the lactate transporters MCT1 and MCT4 (Figure 2, A and B). In addition, the spontaneous lactate release seen from tanycytes cultured in glucose-containing, serum-free defined medium (Figure 2C) was blunted by the addition to the culture medium of the non-metabolizable glucose analog 2-deoxyglucose (2-DG, 50 mM) (P = 0.0016, ordinary 1-way ANOVA followed by Tukey’s post hoc test, n = 5; Figure 2C), which also blunted lactate production within the cells (P = 0.0001, ordinary 1-way ANOVA followed by Tukey’s post hoc test, n = 5; Figure 2D). Since MCTs are responsible for lactate exit from cells, inhibition of tanycytic MCTs by treating the cultures for 30 minutes with 500 μM 4-CIN abrogated the ability of tanycytes to release lactate (P = 0.012, n = 6; Figure 2C) and caused an accumulation of lactate in their cytoplasm (P = 0.0001, n = 6; Figure 2D). These in vitro results indicate that tanycytes could indeed produce and release lactate through their uptake and metabolization of glucose.
Next, to test the possibility that lactate released by tanycytes fuels POMC neurons in the ARH, we asked whether the delivery of lactate into ARH tanycytes could rescue activity in POMC neurons during glucose deprivation in living brain slices. We dialyzed a single tanycyte with 5 mM lactate while performing a whole-cell recording from a distant POMC neuron (50–200 μm apart; Figure 2, E–J, and Supplemental Figure 1, A–C; supplemental material available online with this article; https://doi.org/10.1172/JCI140521DS1). When the tanycyte was dialyzed with lactate, the reduction in action potential firing seen with glucose deprivation in Figure 1D no longer occurred (P = 0.9974, 1-way, repeated-measures ANOVA followed by Tukey’s post hoc test, n = 6 cells, n = 5 mice; Figure 2, H and I); this was true of all the POMC neurons that were patched (n = 9; including some not shown), even when the neurons were at a considerable distance from the patched tanycyte and not in the path of the tanycytic process (Figure 2J). This tanycyte-mediated rescue of POMC neuronal firing was reversed with the loss of the tanycytic patch that sometimes occurred during the course of the experiment (Supplemental Figure 1D), but could be counteracted by bath application of 5 mM lactate (Supplemental Figure 1D) as shown in Figure 1D. We next explored whether selective blocking of lactate production in the patched tanycytes would have an impact on the activity of the POMC neurons with which they are connected, regardless of the presence of physiological levels of glucose (2.5 mM; Figure 2K). When a single tanycyte was dialyzed with the LDH inhibitor oxamate to block the conversion of pyruvate to lactate, it induced a drastic reduction in action potential firing in the paired POMC neuron (P = 0.0143, 1-way, repeated-measures ANOVA followed by Tukey’s post hoc test, n = 6 cells, n = 5 mice), an effect that was rescued by bath application of lactate (P = 0.0474, n = 6 cells, n = 5 mice; Figure 2, L–N). Altogether, these results suggest that tanycytes metabolize glucose into lactate for delivery to the POMC neurons with which they are functionally connected and that this tanycytic lactate production is both necessary and sufficient for the tonic firing of POMC neurons. In addition, the rescue of POMC neuronal activity by tanycyte-delivered lactate was completely suppressed by 500 μM 4-CIN (P = 0.0288, n = 6 cells, n = 5 mice; Figure 2, H and I), indicating that lactate transport through MCTs is required for this effect.
Mct1 and Mct4 expression by tanycytes is required to maintain POMC neuronal activity and energy homeostasis.
To determine the expression profile of Mct in both tanycytes and POMC neurons, we performed quantitative PCR (qPCR) analyses in cells isolated by FACS. We collected POMC neurons from Pomc::Cre tdTomatoloxP-STOP-loxP mice (Figure 3A and Supplemental Figure 2, A–C) and tanycytes from WT mice infused with the AAV1/2 vector expressing GFP under the tanycyte-specific iodothyronine deiodinase 2 (Dio2) promoter (27) into the lateral ventricle (Figure 3A and Supplemental Figure 2, D and F). We found that tanycytes were enriched in Mct1 (P = 0.0009, unpaired Student’s t test, n = 5 and n = 4 mice) and Mct4 transcripts (P = 0.0272, unpaired Student’s t test, n = 5 and 4 mice), whereas POMC neurons were rich in Mct2 mRNA (P = 0.0028, unpaired Student’s t test, n = 5 and n = 4 mice) (Figure 3B). To determine the relative physiological roles of these MCTs in the function of POMC neurons, we first blunted the expression of Mct2 in POMC neurons by injecting into the ARH of Pomc::Cre mice a Cre-dependent FLEXon viral vector expressing an shRNA to silence Mct2. The expression of Mct2 shRNA specifically in POMC neurons (Supplemental Figure 3A) led to a clear increase in cumulative food intake (Supplemental Figure 3B) and a transient trend toward increased weight gain (Supplemental Figure 3C), in keeping with their anorexigenic function and the effect of blocking lactate uptake by these neurons on their activity seen in Figure 2, G–I. Next, we focused on tanycytic MCTs by coinjecting a Cre-dependent FLEXon viral vector expressing shRNAs to silence Mct1 and Mct4 and a Dio2:Cre vector into the lateral ventricle of WT or tdTomatoPOMC mice to target tanycytes. FACS isolation of viral GFP–expressing cells showed that the Dio2:Cre-mediated expression of shRNAs targeting Mct1 and Mct4 decreased the expression of these gene transcripts by 2-fold selectively in tanycytes (ordinary 1-way ANOVA followed by Tukey’s post hoc test; Mct1, P = 0.0231; Mct4, P = 0.0320; n = 4 mice), but not in non-tanycytic cells (Mct1: P = 0.8494, Mct4: P = 0.8944, n = 4 mice; Figure 3, C and D). While Mct1 and Mct4 knockdown (KD) in tanycytes (Mct1/4TanycyteKD) had no effect on the expression of tanycytic markers (unpaired Student’s t test: vimentin, P = 0.2256; Dio2, P = 0.4034; n = 4 mice; Supplemental Figure 4, A and B) or on other genes related to glucose metabolism or transport in tanycytes (unpaired Student’s t test: Mct2, P = 0.8204; Ldha, P = 0.5561; Ldhb, P = 0.5457; Gck, P = 0.1381; Glut1, P = 0.2479; Glut4, P = 0.9174; Cx30, P = 0.7825; Cx43, P = 0.4315; n = 6 mice; Supplemental Figure 4C), it markedly dampened spontaneous neuronal firing in POMC neurons (P = 0.0026, Mann-Whitney U test; n = 26 cells, n = 5 mice; Figure 3, E–G).
Interestingly, Mct1/4TanycyteKD mice gained significantly more weight than did mice injected with the virus expressing scrambled shRNAs (P = 0.0334, unpaired Student’s t test, n = 7 mice per group) (Mct1/4TanScramble; Figure 3H). However, surprisingly, this weight gain was not associated with increased food intake (2-way ANOVA followed by an uncorrected Fisher’s least significant difference [LSD] test; dark phase, P = 0.2454; light phase, P = 0.8866; mean, P = 0.360 [bar graph] and P = 0.2310 [line graph]; n = 6 Mct1/4TanScramble mice and n = 8 Mct1/4TanycyteKD mice) (Figure 3I, see also Supplemental Figure 4D). Furthermore, although these tanycytic Mct1/4-KD mice showed only mild perturbations in energy expenditure (P = 0.04480, 2-way ANOVA followed by an uncorrected Fisher’s LSD test, n = 7 Mct1/4TanScramble mice and n = 8 Mct1/4TanycyteKD mice; Supplemental Figure 4E), they displayed a notable loss of both the linear correlation between food intake and body weight (BW) (Pearson’s correlation; Mct1/4TanScramble, r2 = 0.8087, P = 0.0378; Mct1/4TanycyteKD, r2 = 0.08139, P = 0.5351; n = 7 mice per group; Figure 3J) and between energy expenditure and BW in Mct1/4TanycyteKD mice (Pearson’s correlation; Mct1/4TanScramble, r2 = 0.7796, P = 0.0084; Mct1/4TanycyteKD, r2= 0.2481, P = 0.2553; n = 7 mice per group; Figure 3K). Together, these results demonstrate that the maintenance of energy balance is impaired by the reduced tanycytic expression of Mct1 and Mct4.
Given the disconnect between BW and both food intake and energy expenditure observed above, we further attempted to analyze their respective components to understand the contribution of tanycytic MCTs. An analysis of ambulatory activity showed that, while horizontal displacement in the cage appeared to be unchanged between Mct1/4TanycyteKD and Mct1/4TanScramble mice (P = 0.5215, 2-way ANOVA followed by an uncorrected Fisher’s LSD test; n = 7 Mct1/4TanScramble mice and n = 8 Mct1/4TanycyteKD mice; Supplemental Figure 4F), Z-rearing was significantly diminished in Mct1/4TanycyteKD mice during the dark phase (2-way ANOVA followed by an uncorrected Fisher’s LSD test: dark phase, P = 0.0012; light phase, P = 0.3476; mean, P = 0.0324 (bar graph) and P = 0.0305 (line graph); n = 7 Mct1/4TanScramble mice and n = 8 Mct1/4TanycyteKD mice; Figure 3L, see also Supplemental Figure 4G). This suggests that feeding patterns may differ between these 2 experimental groups despite similar cumulative food intake (Figure 3I and Supplemental Figure 4D). Indeed, an analysis of feeding patterns showed that Mct1/4TanycyteKD mice ate less frequently than did Mct1/4TanScramble mice (2-way ANOVA followed by an uncorrected Fisher’s LSD test: dark phase, P = 0.0459; light phase, P = 0.3042; mean, P = 0.0037; n = 5 Mct1/4TanScramble mice and n = 7 Mct1/4TanycyteKD mice; Figure 3M), but that the size of their meals was significantly increased (2-way ANOVA followed by an uncorrected Fisher’s LSD test: dark phase, P = 0.0337; light phase, P = 0.5919; mean, P = 0.1018; 5 Mct1/4TanScramble mice and n = 7 Mct1/4TanycyteKD mice; Figure 3N).
Altogether, these data suggest that tanycytic lactate shuttles control the activity of POMC neurons and hence contribute to the adaptation of the feeding pattern of the individual to energy needs, i.e., glucose availability.
POMC neuronal activity depends on gap junction–mediated tanycytic metabolic networks.
Intriguingly, in the paired tanycyte-neuron recording setup illustrated in Figure 2E, Lucifer yellow filling the patch pipette diffused from the patched tanycyte into neighboring tanycytes along the wall of the 3V. This phenomenon, which we also observed when using biocytin-filled patch pipettes (Supplemental Figure 5, A and B), suggests the existence of a functional tanycytic network in the ARH, similar to the gap junction–mediated astrocytic networks previously described in the brain (28), including in the lateral hypothalamic area (24). The intercellular diffusion of biocytin was blunted by the bath application of the gap junction blocker carbenoxolone (CBX, 50 μM) (Supplemental Figure 5, C and D, and ref. 28), suggesting that tanycytes are also connected by gap junctions. Under control conditions, biocytin diffused through the cell bodies of ARH tanycytes over 100–200 μm along the wall of the 3V and into tanycytic processes extending into the tissue, but not into cells expressing the neuronal marker NeuN (Supplemental Figure 5B). In the presence of CBX (50 μM, 30 min), recorded POMC neurons showed a marked decrease in their firing activity (P = 0.0312, Wilcoxon matched-pairs test, n = 6 cells, n = 4 mice; Figure 4, A–C), an effect that could be prevented by bath application of exogenous lactate (P = 0.625, Wilcoxon matched-pair test, n = 5 cells, n = 4 mice; Figure 4, D and E). Interestingly, the treatment of cultured tanycytes with CBX phenocopied the effects of 4-CIN, i.e., it also prevented the release of lactate into the conditioned medium (P = 0.0355, 1-way repeated-measures ANOVA followed by Tukey’s post hoc test, n = 6; Figure 2C) and led to its accumulation in the cytoplasm of tanycytes (P = 0.0009, 1-way, repeated-measures ANOVA followed by Tukey’s post hoc test, n = 6; Figure 2D). Together, these results demonstrate functional gap-junctional coupling between tanycytes surrounding POMC neurons in the ARH and raise the possibility that such glial metabolic networks play a role in the regulation of POMC neuronal activity that is greater than the sum of the roles of individual tanycytes.
In agreement with previous studies (29, 30), we found that tanycytes expressed the gap junction protein connexin 43 (Cx43), with a marked enrichment in ARH tanycytes when compared with median eminence (ME) tanycytes, which are responsible for the transport of glucose and other peripheral metabolic signals into the CSF (refs. 22, 25, 31 and Supplemental Figure 5, E–G). To determine the functional role of these Cx43-mediated tanycytic networks in the control of POMC neuron activity, we next selectively knocked out the Gja1 gene encoding Cx43 in tanycytes by infusing the recombinant TAT-Cre protein into the 3V of Cx43loxP/loxP mice (Figure 4F), a procedure that we have extensively characterized before (4, 32). FACS isolation of TAT-Cre–injected Cx43+/+ tdTomatoloxP-STOP-loxP (Cx43+/+ tdTomatoTanycyte) and Cx43loxP/loxP tdTomatoloxp-STOP-loxP (Cx43TanycyteKO tdTomatoTanycyte) mice (Supplemental Figure 6), demonstrated that Cx43 expression was significantly diminished in Tomato-positive tanycytes (P = 0.0449, unpaired Student’s t test, n = 6 mice; Figure 4G), but not in Tomato-negative cells (P = 0.8611, unpaired Student’s t test, n = 6 mice; Figure 4G), which comprise astrocytes that are also known to abundantly express Cx43 (24), in floxed Cx43 mice. In line with our recent data showing that our TAT-Cre infusion procedure causes genetic recombination in approximately 60% of ME/ARH tanycytes (33), Cx43 protein expression was fully extinguished in the subset of tanycytes expressing high levels of Tomato (Supplemental Figure 5I). This submaximal invalidation of Cx43 protein expression in tanycytes was sufficient to abolish the gap junction–mediated tanycytic network, as shown by the absence of intercellular diffusion following biocytin injection into a single ARH tanycyte via a patch pipette (P = 0.0006, Mann-Whitney U test, n = 7 cells from n = 6 Cx43loxP/loxP mice and n = 7 cells from n = 6 Cx43TanycyteKO mice; Supplemental Figure 5, J and K). Consequently, the selective deletion of Cx43 in tanycytes markedly diminished the ability of energy metabolites to be trafficked between ARH tanycytes, as shown by the injection of a single tanycyte with the fluorescent glucose derivate 2-(N-[7-nitrobenz-2-oxa-1,3-diazol-4-yl]amino)-2-deoxyglucose (2-NBDG, 2 mg/mL, ref. 28, and Figure 4, H and I) (P = 0.0011, unpaired Student’s t test, n = 5 cells from n = 2 Cx43loxP/loxP mice and n = 10 cells from n = 4 Cx43TanycyteKO mice). This deletion of Cx43 specifically in tanycytes also decreased spontaneous POMC neuronal firing (P = 0.0043, Mann-Whitney U test, n = 6 cells from n = Cx43loxP/loxP mice and n = 5 cells from n =4 Cx43TanycyteKO mice; Figure 4, J–L), which was restored by the bath application of 5 mM lactate in the presence of 2.5 mM glucose (P = 0.0312, Wilcoxon matched-pairs test, n = 6 cells, n = 5 mice; Figure 4, M and N). However, in Cx43loxP/loxP littermates, the bath application of lactate had no effect on POMC neuronal activity, which was normal (P = 0.6042, paired Student’s t test, n = 6 cells, n = 6 mice; Supplemental Figure 5, L and M). These results suggest that the decreased activity of POMC neurons in Cx43TanycyteKO mice resulted from a deficiency in the trafficking of glucose-derived lactate through the tanycytic network.
Tanycytic Cx43 KO impairs changes in ARH lactate levels in response to blood glucose variation.
CSF glucose levels, which are maintained at approximately 60% of serum glucose levels (11, 12), have long been proposed to complete a feedback loop in the homeostatic control of food intake and BW (34). Regardless of its source, this role of glucose in energy homeostasis appears to require the production of lactate by glial cells in the hypothalamus (17), and central lactate metabolism has been shown to regulate food intake (35, 36). We thus next assessed the putative involvement of gap junction–mediated tanycytic metabolic networks, which metabolize glucose into lactate (Figure 2, C, D, and K–M), in controlling the bioavailability of lactate in hypothalamic tissue in a physiological context. Microdialysis experiments in the ARH of Cx43loxP/loxP mice and littermates in which Cx43 was knocked out (Cx43TanycyteKO) using either the TAT-Cre recombinant protein or the Dio2:Cre viral approach (see Figure 5C, right panel for a comparison of the 2 methods), before and after i.p. injection of saline and glucose (2 g/kg BW; Figure 5, A–C) showed that, while saline injection did not alter lactate levels (2-way repeated-measures ANOVA followed by an uncorrected Fisher’s LSD test, n = 6 Cx43loxP/loxP and n = 10 Cx43TanycyteKO mice; vehicle, 40 min vs. basal, P = 0.6663 for Cx43loxP/loxP mice and P = 0.3059 for Cx43TanycyteKO mice\), glucose injection quickly promoted an increase in the hypothalamic levels of lactate in Cx43loxP/loxP mice (P = 0.0008: vehicle, 20 min vs. glucose, 20 min; P < 0.0001: vehicle, 40 min vs. glucose, 40 min). In contrast, we found that peripheral glucose injection had no effect on hypothalamic levels of lactate in Cx43TanycyteKO mice (P = 0.1153: vehicle, 20 min vs. glucose, 20 min; P = 0.0049: vehicle, 40 min vs. glucose, 40 min), which remained lower than in Cx43loxP/loxP animals after glucose injection (P = 0.0012, at 40 min). Our results suggest that tanycytic metabolic networks along the wall of the 3V that are in contact with both the blood circulation and the CSF are actively involved in integrating the changes in circulating glucose levels and translating these changes into a local lactate signal that can be perceived by ARH neurons and used to drive their activity. Furthermore, downregulation of the expression of the glucose transporter Glut2 (P = 0.0071, unpaired Student’s t test, n = 6 mice) and the lactate dehydrogenase Ldhb (P = 0.0119, unpaired Student’s t test, n = 6 mice) in tanycytes with Cx43 KO (Figure 5D) may further accentuate the shortage of tanycytic lactate supply to ARH neurons in mutant mice.
KO of Cx43 in ARH tanycytes causes weight gain and modulates substrate consumption.
Supporting the role of the glucose-sensitive tanycytic network in modulating the activity of POMC neurons controlling food intake in response to the peripheral energy state, Cx43TanycyteKO mice had increased food intake (P = 0.0428, unpaired Student’s t test, n = 7 Cx43loxP/loxP and n = 9 Cx43TanycyteKO mice; Figure 5E), BW (P = 0.0121, unpaired Student’s t test, n = 9 mice per group; Figure 5F), and fat mass content (P = 0.0287, unpaired Student’s t test, n = 8 Cx43loxP/loxP and n = 9 Cx43TanycyteKO mice; Figure 5G), but no change in lean mass (P = 0.1139, Mann-Whitney U test, n = 8 Cx43loxP/loxP and n = 9 Cx43TanycyteKO mice; Figure 5H), when compared with vehicle-injected Cx43loxP/loxP littermates 10 days after TAT-Cre injection into the 3V. Given that the central melanocortin system not only modulates feeding but also controls energy partitioning and expenditure (37–40), we further investigated the role of tanycytic Cx43 in the regulation of energy homeostasis. Cx43loxP/loxP mice were subjected to indirect calorimetry before and after TAT-Cre injection. After TAT-Cre injection, Cx43TanycyteKO mice, in addition to the increase in food intake noted above (P = 0.0001, 2-way ANOVA, uncorrected Fisher’s LSD test, n = 7 mice per group; Figure 5I), showed a decrease in ambulatory activity (P < 0.0001, 2-way ANOVA, uncorrected Fisher’s LSD test, n = 7 mice per group; Figure 5J) and energy expenditure (P = 0.0001, 2-way ANOVA, uncorrected Fisher’s LSD test, n = 7 mice per group; Figure 5K). Importantly, selective KO of Cx43 in tanycytes also induced a marked increase in the respiratory exchange ratio (RER) (P = 0.0147, 2-way ANOVA, uncorrected Fisher’s LSD test, n = 7 mice per group; Figure 5L) together with a decrease in oxygen consumption (Figure 5M), during both the resting phase (day; P = 0.0394, unpaired Student’s t test, n = 7 mice per group) and the active phase (night; P = 0.0261, unpaired Student’s t test, n = 7 mice per group). The higher RER in Cx43TanycyteKO mice suggests that nutrient partitioning was altered, favoring the use of carbohydrates rather than fatty acids as an energy source in these mice, contrary to the normal situation (41). In addition to a dramatic impairment of POMC neuronal activity (Figure 4, K and L), these changes in metabolism after selective KO of Cx43 in tanycytes were associated with an upregulation of transcripts for NPY in the ARH (P = 0.0492, unpaired Student’s t test, n = 6 mice), whereas transcripts for Pomc (P = 0.6335, unpaired Student’s t test, n = 6 mice), Cart (P = 0.4184, unpaired Student’s t test, n = 6 mice), and Agrp (P = 0.4722, unpaired Student’s t test, n = 6 mice) appeared to be unchanged in the mutant mice (Figure 5N). The gap junction–mediated ARH tanycytic network thus appears to be a physiologically relevant component of metabolic regulation, modulating feeding behaviors and the establishment of energy balance in response to peripheral conditions.
Discussion
The question of what energy metabolites reach POMC neurons in the ARH has a 2-fold significance: first, like every other type of neuron, POMC neurons need an energy source to drive their activity; but second, and more important, the activity of these anorexigenic neurons itself controls the energy state of the organism, making it essential for them to sense metabolic signals triggered by nutrient intake or energy consumption at the periphery.
We believe that our results shed new light on a long-established but ill-understood phenomenon (10, 42, 43) by demonstrating that POMC neurons depend on the bioavailability of lactate for their activity and that this lactate is metabolized from glucose and distributed to neurons by a network of ARH tanycytes. Intriguingly, the dramatic suppression of POMC neuronal activity in mice in which lactate transfer by tanycytes was blocked indicates that, with regard to this neuronal population at least, the astrocyte-neuron lactate shuttle (23, 44), which up to now was thought to explain the regulation of synaptic transmission and the fueling of neuronal activity in neocortical (28) and hypothalamic brain regions (24), has been almost completely replaced by a shuttle consisting of another glial cell type, the tanycyte. This places tanycytes at the center of the intercellular communication processes used by hypothalamic circuits regulating energy homeostasis, where they play the role of bloodhounds of the metabolic brain, “sniffing” out the availability of glucose and conveying this information to neurons in such a way as to modulate their activity. Indeed, studies in human patients lacking the glucose transporter GLUT1 suggest that CSF-borne peripheral glucose is an important source of lactate in the brain (45). The peculiar position occupied by tanycytes, at the interface of both the peripheral circulation and the CSF, makes them ideal candidates for the detection and perhaps triangulation of circulating metabolic signals, potentially providing qualitative in addition to quantitative information. Importantly, the fact that the energy metabolite released by ARH tanycytes and used by POMC neurons to adjust their activity to physiological demands is lactate and not glucose provides a plausible explanation for why POMC neurons, whose function it is to respond to changes in glucose levels, do not themselves appear to be capable of sensing glucose (9). Furthermore, consistent with the notion that non-neuronal cells are functionally involved in the regulation of metabolic sensing and the central control of systemic metabolism (33, 46–48), recent studies have reported that insulin receptor expression in astrocytes is involved in the regulation of glucose uptake at the blood-brain barrier (46) and may participate in the glucose-induced activation of POMC neurons, possibly via changes in the glial coverage of POMC neuronal cell bodies (46, 49). It remains to be determined whether and how this newly uncovered role for astrocytes modulates the role of tanycytes, or vice versa, in the fine-tuning of POMC neuronal function.
Intriguingly, our findings reveal both the involvement of the monocarboxylate transporters MCT1 and MCT4 and a previously unknown role for Cx43 gap junction channels in the transfer of lactate to POMC neurons by ARH tanycytes. Indeed, the connexins appear to constitute the molecular basis of the newly discovered metabolic network formed by these CSF-contacting tanycytes. The ability to mobilize and transfer lactate through a large number of interconnected cells may serve to increase the sensitivity of the response to any peripheral signal beyond the sum of the responses of a number of unconnected cells, each releasing its own load of lactate. In addition to this amplification of the efficiency with which a metabolic signal reaches its targets, the existence of these gap junction–mediated tanycytic networks could improve the adaptive metabolic response by synchronizing the release of energy metabolites to neuronal populations that need to be informed about variations in physiological state.
Keeping in mind that blocking or knocking out Cx43 specifically in ARH tanycytes phenocopies the effect of the MCT inhibitor 4-CIN, the potential involvement of connexin hemichannels themselves in the secretion of lactate by tanycytes (50) or a signaling role for gap junctions above and beyond the transfer of metabolites between tanycytes cannot be ruled out. A putative signaling role for Cx43 in the control of tanycytic lactate secretion is suggested by our in vitro data showing that treatment of cultured tanycytes with the gap junction blocker carbenoxolone altered lactate release (Figure 2C). Our in vivo results also strengthen this possibility, as they showed that knocking out Cx43 in tanycytes resulted in the downregulation of 2 critical molecules specifically in these cells: the glucose transporter Glut2, which has recently been suggested to promote the rapid transfer of circulating glucose into the CSF at the ME (31), and the lactate dehydrogenase Ldhb. Together with the recent demonstration that Cx43 can directly act as a transcriptional regulator (51), these results raise the intriguing possibility that Cx43 may form a functional micronetwork with other genes, e.g., Glut2 and Ldhb, in tanycytes, although it remains to be determined whether such a micronetwork would simply dictate the terms of glucose conversion into lactate, or would itself be subject to feedback regulation by accumulating intracellular lactate that has nowhere to go when Cx43 or the MCTs are blocked.
The physiological relevance of these results is demonstrated by the phenotype of mice lacking Cx43 in ARH tanycytes. Their inability to metabolize lactate from glucose and the resulting lower activity of POMC neurons cause a profound metabolic dysfunction represented by hyperphagia, increased weight gain and adiposity, decreased energy expenditure, and an increased RER, indicating a switch from lipid to carbohydrate use. It is well established that the central melanocortin system, of which the POMC neurons form an integral element, regulates all these parameters. Interestingly, our mice in which tanycytic Cx43 was inactivated appeared to phenocopy those lacking POMC (52, 53) or melanocortin receptor 4 (54). This, together with the fact that the selective impairment of Mct1 and Mct4 expression in tanycytes is as effective at inhibiting POMC neuronal activity as knocking out Cx43 in these cells, strongly suggests that the low bioavailability of tanycytic lactate shuts down the activity of POMC neurons and that this deficiency cannot be compensated by any other neuroglial pathway. Strengthening this idea are our patch-clamp experiments showing that the direct infusion of the lactate dehydrogenase inhibitor oxamate into the Cx43-connected tanycytic network, effectively abolishing the conversion of bath-borne glucose into lactate by tanycytes, sufficed to blunt the spontaneous firing of POMC neurons in living brain slices. In addition, the selective knockdown of Mct1 and Mct4 expression in tanycytes also provided a more nuanced view of the manner in which these cells influence food intake. Indeed, the lack of tanycytic Mct1 and Mct4 not only dramatically impaired the spontaneous activity of POMC neurons, but the resulting BW gain occurred without a marked change in cumulative food intake, instead altering meal patterns and uncoupling both energy intake and energy expenditure from bodily needs, unlike the more straightforward effect observed when Mct2 alone was knocked down in POMC neurons. These results agree with previous studies showing that the activity of a subpopulation of ARH POMC neurons projecting to the brainstem controls feeding behavior and that the inhibition of melanocortinergic activity in the brainstem nucleus of the solitary tract increases meal size (55, 56). Another interesting question, however, is whether the tanycytic lactate shuttle or gap-junctional network is required for the activity of other hypothalamic neurons, such as the orexigenic agouti-related peptide (AgRP) and neuropeptide Y (NPY) neurons, which play a role opposite that of POMC neurons in energy homeostasis (6, 9), but which are also rich in MCT2 and may play a confounding role when MCT2 is silenced in POMC neurons (57). Our results indeed show that knocking out Cx43 in tanycytes upregulates NPY transcripts in the mediobasal hypothalamus. Whether this change, which may, at least in part, contribute to the increased feeding seen in mutant mice, is a direct or an indirect consequence of the impaired tanycytic lactate shuttle remains to be explored.
In conclusion, our results reveal an unexpected role for tanycytic networks connected by gap junctions, thanks to their unique position and ability to convert glucose into lactate, as both the suppliers of energy metabolites to fuel the activity of hypothalamic POMC neurons that regulate energy homeostasis and as the sensors of the peripheral energy state upstream of these neurons. Further investigation into how tanycytes, which bridge the blood and CSF, perceive and translate this information for neurons could clear the way for potential treatments for metabolic disorders such as obesity and type 2 diabetes.
Methods
Animals
The experiments used WT C57Bl/6J and single-, double-, or triple-transgenic Cx43loxP/loxP (RRID_JAX008039), Pomc::Cre (RRID:IMSR_JAX:005965), tdTomatoloxP-STOP-loxP (RRID:IMSR_JAX007914), and Cx43loxP/loxP tdTomatoPOMC mice maintained on a C57Bl6 background as detailed in the Supplemental Methods. All mice were bred and housed in a temperature- and humidity-controlled room on a 12-hour light/12-hour dark cycle with ad libitum access to food and water.
Stereotaxic delivery of viruses to manipulate the expression of Mct in POMC neurons and tanycytes
In POMC neurons.
AAV8[FLEXon]-SYN1 (EGFP:miR30_MCT-2[mSlc16a7]) (1.17 × 1013 PFU/mL, Vector Builder, Vector ID: VB200715-1173hzs) and AAV-GFP scrambled (1.1 × 1013 PFU/mL, VectorBuilder) viral vectors were injected into the ARH of POMC-Cre mice (58, 59). The ARH was targeted bilaterally, and adeno-associated viruses (AAVs) were delivered at a rate of 0.1 μL/min for 5 minutes (0.5 μL/injection site) according to the following coordinates: –1.5 mm posterior to bregma, ± 0.2 mm lateral to midline, and –6 mm below the surface of the skull. Specific transduction of POMC neurons by AAVs was evaluated by immunohistochemistry. BW and food intake were recorded over 5 weeks after the surgery.
In tanycytes.
WT C57Bl/6J or tdTomatoPOMC mice were injected with either 2 μL of a 1:1 mixture of AAV1/2[FLEXon]-CMV (EGFP:miR30_shRNA-MCT-1[mSlc16a1]_shRNA-MCT-4[mSlc16a3]) (at a titer of 4.4 × 109 gp/μL; VectorBuilder, vector ID: VB200716-1259yky) and AAV1/2-Dio2:Cre (at a titer of 2.2 × 1010 gp/μL) (27) (n = 4), or 2 μL of a 1:1 mixture of AAV1/2[FLEXon]-CMV (EGFP:miR30_scramble) (at a titer of 1.6 × 1010 gp/μL) and AAV1/2-Dio2:Cre (at a titer of 2.2 × 1010 gp/μL) (n = 4) at a rate of 0.3 μL/min. All animals underwent injection into the lateral ventricle (coordinates from bregma, anteroposterior: –0.3 mm; midline: –1 mm; and dorsoventral: –2.5 mm from the skull).
Stereotaxic TAT-Cre delivery
Tanycyte-specific Cx43 deletion was performed using the Cre/LoxP system by stereotaxically infusing a TAT-Cre fusion protein into the 3V (2 μL; 0.3 μL/min; anteroposterior/midline/dorsoventral coordinates: –1.7 mm/0 mm/–5.6 mm) in isoflurane-anesthetized Cx43loxP/loxP mice or Cx43loxP/loxP tdTomatoPOMC mice, 1 week before experiments. The TAT-Cre fusion protein was produced as described previously (4). Control mice were injected with a vehicle solution.
Brain slice preparation
Electrophysiological recordings were performed on living brain slices containing the tuberal region of the hypothalamus from 8- to 12-week-old mice as previously described (59). Briefly, mice were anesthetized with isoflurane and decapitated. The brain was removed and rapidly placed in ice-cold ACSF containing the following: 120 mM NaCl, 3.2 mM KCl, 1 mM NaH2PO4, 26 mM NaHCO3, 1 mM MgCl2, 2 mM CaCl2, 2.5 mM glucose (290 mOsm, pH 7.4) and bubbled with 95% O2 to 5% CO2. Three 250 μm thick coronal hypothalamic slices containing the arcuate nucleus were cut using a VT1200 vibratome (Leica). The slices were incubated at 34°C in oxygenated ACSF for a recovery period of 1 hour, and then at room temperature until the recording.
Patch-clamp recording
For patch-clamp recording, individual brain slices were placed in a submerged recording chamber (Warner Instruments), immobilized by a nylon grid, and continuously perfused at a rate of 3 mL/min with oxygenated ACSF maintained at 32.8°C by a heater controller (TC-344C, Warner Instruments). POMC neurons and ARH tanycytes were visualized and identified under ×40 magnification using an upright fluorescence microscope with infrared differential interference contrast (DM-LFSA, Leica) and an ORCA-Flash4.0 digital CMOS camera (Hamamatsu). Recording pipettes were pulled from borosilicate glass capillaries (1.5 mm outer diameter, 1.12 mm inner diameter; World Precision Instruments) using a P1000 Flaming Brown puller (Sutter Instruments) and had a resistance of 4–6 MΩ when filled with an internal solution containing the following: 123 mM K-gluconate, 2 mM MgCl2, 8 mM KCl, 0.2 mM EGTA, 4 mM Na2-ATP, 0.3 mM Na2-GTP, and 10 mM HEPES, pH 7.3, with KOH. In paired recordings of a tanycyte and a neuron, sodium l-lactate (5 mM, Alfa Aesar, catalog L14500, Chemical Abstracts Service [CAS]: 867-56-1) was also added to the internal solution of the tanycyte pipette. Pipettes were placed in contact with a POMC neuron or an ARH tanycyte using a PCS-5400 micromanipulator (Thorlabs). Whole-cell patch-clamp recordings were performed in current-clamp mode using a Multiclamp 700B Amplifier, digitized with the Digidata 1322A interface and acquired with pClamp 10.2 software (Molecular Devices). Data were filtered at 1 kHz and sampled at 5 kHz.
For exogenous glucose deprivation studies, the osmolarity of the ACSF containing 0 mM d-glucose was adjusted with sucrose. All drugs tested (4-CIN, 500 μM, MilliporeSigma, catalog C2020, CAS: 28166-41-8; sodium oxamate, 10 mM, MilliporeSigma, catalog O2751, CAS: 565-73-1; sodium l-lactate, 5 mM, Alfa Aesar; sodium pyruvate, 5 mM, MilliporeSigma, catalog P2256, CAS: 113-24-6; and CBX, 50 μM, MilliporeSigma, catalog C4790, CAS: 7421-40-1) were applied to the perfusion system after stable baseline recording.
Recordings were analyzed using Clampfit 10.2 in pClamp software (Molecular Devices). For each recording, the membrane potential and mean firing rate were determined before and during the bath application of drugs. Neurons were considered responsive when a change of more than 20% in the firing rate was observed. The peak response was determined, and the number of spikes was counted 3 minutes before and after the peak effect.
For glucose and dye diffusion experiments, the internal solution contained the fluorescent glucose derivate 2-NBDG (2 mg/mL, Invitrogen, Thermo Fisher Scientific, catalog N13195, CAS: 1 86689-07-6) or biocytin (2 mg/mL, MilliporeSigma, catalog B4261, CAS: 576-19-2), respectively. Recorded cells were loaded with these solutions for 20 minutes in current-clamp mode. The intercellular diffusion of 2-NBDG was captured online with a digital camera just after recording, and the diffusion distance was analyzed with Fiji software. Biocytin diffusion was revealed by Alexa Fluor 488 streptavidin (Invitrogen, Thermo Fisher Scientific, catalog S11223) as detailed in the Supplemental Methods and analyzed using an Axio Imager Z2 Apotome microscope (AxioCam 504 MRm camera, Zeiss). To inhibit gap-junctional communication, slices were pretreated for 20 minutes with 50 μM CBX.
For dye diffusion during paired tanycyte-neuron recordings, 1 ARH tanycyte was recorded and filled with the gap junction–permeable lucifer yellow CH dilithium salt (1 mg/mL; MilliporeSigma, catalog L0259, CAS: 67769-47-5) through the patch pipettes; 1 neighboring POMC neuron was then similarly recorded and filled with the membrane-impermeable dye Alexa Fluor 594 Hydrazide (40 mM; Invitrogen, Thermo Fisher Scientific, catalog A10438). Images were captured 20 minutes after recording using a digital camera.
Primary cultures of tanycytes
Primary cultures of tanycytes were generated by isolating the ME of 10-day-old Sprague-Dawley rats (Janvier Laboratories), as described previously (26), and processed as described in the Supplemental Methods.
FACS and qPCR
FACS isolation of hypothalamic neurons and tanycytes and subsequent qPCR analyses were performed according to previously described protocols (33, 60), with some adaptations, as detailed in the Supplemental Methods.
Immunochemistry
Immunocytofluorescence protocols are detailed in the Supplemental Methods. The following primary antibodies were used: anti-Cx43 (MilliporeSigma, catalog AB1727, RRID:AB_2294609, 1:200); anti-MCT1 (MilliporeSigma, catalog AB1286, RRID:AB_11212410, 1:100); anti-MCT4 (MilliporeSigma, 1:200); anti-vimentin (MilliporeSigma, catalog AB3314P, RRID:AB_2286063, 1:1000 and Dako, catalog M0725, RRID:AB_10013485, 1:100); anti-NeuN (1:1000; MilliporeSigma, catalog MAB377, RRID:AB_2298772); anti-POMC propeptide (1:200; Phoenix Pharmaceuticals, catalog H02930, RRID:AB_2307442); and anti-GFP (1:1000; Invitrogen, Thermo Fisher Scientific, catalog A10262, RRID:AB_2534023). Immunofluorescence images were captured using a Zeiss Axio Imager Z2 Apotome microscope or a Zeiss LSM 710 confocal microscope.
Metabolic studies
Analysis of basal metabolism.
Mice were analyzed for total energy expenditure, O2 consumption, CO2 production, food intake, and ambulatory movements (total beam breaks/hour) using calorimetric cages (TSE Systems) and standard procedures published by others (61, 62). Mice were individually housed and acclimatized to the cages for 48 hours before experimental measurements.
BW and composition.
Fat and lean tissue mass was determined by nuclear magnetic resonance (MiniSpec mq 7.5, RMN Analyser, Bruker) according to the manufacturer’s recommendations.
In vivo brain microdialysis
Male Cx43loxP/loxP and Cx43TanycyteKO mice weighing 30–35 g were deeply anesthetized with isoflurane (3% in 1 L/min airflow) in an induction chamber and placed in a stereotaxic apparatus equipped with a mask to maintain anesthesia throughout the experiment (isoflurane 1% in 0.7 L/min airflow). Core body temperature was maintained at 37°C with an electrical blanket controlled by a thermostat. A microdialysis cannula (CMA7, 6 kDa, 2 mm membrane length; CMA Microdialysis AB) was implanted over the hypothalamic area using stereotaxic coordinates (anteroposterior: –1.4, lateral: –0.3, ventral: –6.0 mm relative to bregma). The microdialysis probe was then perfused with sterile ACSF (CMA Perfusion Fluid CNS containing 147 mM NaCl, 2.7 mM KCl, 1.2 mM CaCl2, and 0.85 mM MgCl2) at a rate of 2 μL/min using a microinjection pump (CMA 402; CMA). Following a stabilization period of 60 minutes (2 dialysates of 10 minutes each were collected at 40 minutes and 50 minutes), a sterile vehicle injection (i.p., 0.9% NaCl) was administered to the mice, and 4 dialysates of 10 minutes each were recovered. After 100 minutes, a glucose solution was administered to the mice (i.p., 2 g/kg in saline), and 7 dialysates of 10 minutes each were recovered. Brain dialysates were placed in a fraction collector (CMA/820) during the experiment and immediately stored at –80°C until analysis. At the end of the experiment, mice were euthanized by decapitation, and brains were stored immediately in fresh 4% paraformaldehyde. The lactate content of microdialysates from the brain was measured using the luminometric Lactate-Glo Assay Kit (Promega), according to the manufacturer’s protocol, and a Varioskan LUX microplate reader (Thermo Fisher Scientific).
Statistics
Data are presented as the mean ± SEM. All statistical analyses were performed using GraphPad Prism, version 7 (GraphPad Software) and are reported in Supplemental Table 1. To compare 2 groups, an unpaired or paired 2-tailed Student’s t test was used for normal distributions and a Wilcoxon matched-pairs test or a Mann-Whitney U test was performed for non-Gaussian distributions. To compare several groups, a 1-way ANOVA followed by Tukey’s post hoc multiple comparison test or a 2-way ANOVA followed by an uncorrected Fisher’s least significant difference (LSD) test was used. A Repeated-measures ANOVA was used when multiple measurements were made over time in the same groups. P values of less than 0.05 were considered statistically significant.
Study approval
Ethics approval for animal studies was obtained from the French Ministry of National Education, Higher Education and Research (APAFIS no. 2617-2015110517317420 v5 and APAFIS no. 13387-2017122712209790 v9) and by the Ethics Committee of the University of Santiago de Compostela, in accordance with European Union norms for experimental animals.
Author contributions
TL and JC performed the electrophysiological and neuroanatomical experiments. FS performed the experiments in primary cultures. JC, EC, and MI conducted the metabolic phenotyping of the mice. DF, MI, and IMC performed the microdialysis experiments. TL, MI, DF, NDSL, VH, and HMF conducted experiments involving AAVs. TL, JC, MI, DF, SR, MS, RN, and VP designed and planned the study. All authors contributed to the preparation of the manuscript.
Supplementary Material
Acknowledgments
This work was supported by the European Research Council (ERC) Synergy Grant WATCH (grant 810331, to RN, VP, and MS), the H2020-MSCA-IF-2014 (grant ID656657, to JC), and the H2020-MSCA-IF-2016 (grant 748134, to MI), and the Region Hauts-de-France VisionAIRR (grant 189090). We thank Meryem Tardivel (confocal microscopy) and Nathalie Jouy (flow cytometry) from the BioImaging Center of Lille (BiCeL) and Julien Devassine (animal core facility) of the UMS2014-US41 for their expert technical support.
Version 1. 07/29/2021
In-Press Preview
Version 2. 09/15/2021
Electronic publication
Funding Statement
ERC Synergy Grant WATCH
VisionAIRR Grant
Footnotes
Conflict of interest: The authors have declared that no conflict of interest exists.
Copyright: © 2021, American Society for Clinical Investigation.
Reference information: J Clin Invest. 2021;131(18):e140521.https://doi.org/10.1172/JCI140521.
See the related Commentary at Cooperative tanycytes fuel the neuronal tank.
Contributor Information
Tori Lhomme, Email: tori.lhomme@inserm.fr.
Jerome Clasadonte, Email: jerome_clasadonte@hotmail.com.
Monica Imbernon, Email: monica.imbernon@inserm.fr.
Daniela Fernandois, Email: daniela.fernandois@inserm.fr.
Florent Sauve, Email: florent.sauve@inserm.fr.
Emilie Caron, Email: emilie.caron@inserm.fr.
Violeta Heras, Email: violeta.heras@usc.es.
Ines Martinez-Corral, Email: ines.martinez-corral@inserm.fr.
Markus Schwaninger, Email: markus.schwaninger@pharma.uni-luebeck.de.
Ruben Nogueiras, Email: ruben.nogueiras@usc.es.
Vincent Prevot, Email: vincent.prevot@inserm.fr.
References
- 1.De Vivo DC, et al. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med. 1991;325(10):703–739. doi: 10.1056/NEJM199109053251006. [DOI] [PubMed] [Google Scholar]
- 2.Wang D, et al. A mouse model for Glut-1 haploinsufficiency. Hum Mol Genet. 2006;15(7):1169–1179. doi: 10.1093/hmg/ddl032. [DOI] [PubMed] [Google Scholar]
- 3.Fox PT, et al. Nonoxidative glucose consumption during focal physiologic neural activity. Science. 1988;241(4864):462–464. doi: 10.1126/science.3260686. [DOI] [PubMed] [Google Scholar]
- 4.Langlet F, et al. Tanycytic VEGF-A boosts blood-hypothalamus barrier plasticity and access of metabolic signals to the arcuate nucleus in response to fasting. Cell Metab. 2013;17(4):607–617. doi: 10.1016/j.cmet.2013.03.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Dunn-Meynell AA, et al. Relationship among brain and blood glucose levels and spontaneous and glucoprivic feeding. J Neurosci. 2009;29(21):7015–7022. doi: 10.1523/JNEUROSCI.0334-09.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Claret M, et al. AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons. J Clin Invest. 2007;117(8):2325–2336. doi: 10.1172/JCI31516. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Parton LE, et al. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature. 2007;449(7159):228–232. doi: 10.1038/nature06098. [DOI] [PubMed] [Google Scholar]
- 8.Levin BE, et al. Neuronal glucosensing: what do we know after 50 years? Diabetes. 2004;53(10):2521–2528. doi: 10.2337/diabetes.53.10.2521. [DOI] [PubMed] [Google Scholar]
- 9.Fioramonti X, et al. Characterization of glucosensing neuron subpopulations in the arcuate nucleus: integration in neuropeptide Y and pro-opio melanocortin networks? Diabetes. 2007;56(5):1219–1227. doi: 10.2337/db06-0567. [DOI] [PubMed] [Google Scholar]
- 10.Levin BE. Neuronal glucose sensing: still a physiological orphan? Cell Metab. 2007;6(4):252–254. doi: 10.1016/j.cmet.2007.09.005. [DOI] [PubMed] [Google Scholar]
- 11.Fishman RA. Carrier transport of glucose between blood and cerebrospinal fluid. Am J Physiol. 1964;206:836–844. doi: 10.1152/ajplegacy.1964.206.4.836. [DOI] [PubMed] [Google Scholar]
- 12.Nigrovic LE, et al. Relationship between cerebrospinal fluid glucose and serum glucose. N Engl J Med. 2012;366(6):576–578. doi: 10.1056/NEJMc1111080. [DOI] [PubMed] [Google Scholar]
- 13.Magistretti PJ, Allaman I. Lactate in the brain: from metabolic end-product to signalling molecule. Nat Rev Neurosci. 2018;19(4):235–249. doi: 10.1038/nrn.2018.19. [DOI] [PubMed] [Google Scholar]
- 14.Prevot V, et al. The versatile tanycyte: a hypothalamic integrator of reproduction and energy metabolism. Endocr Rev. 2018;39(3):333–368. doi: 10.1210/er.2017-00235. [DOI] [PubMed] [Google Scholar]
- 15.Garcia-Caceres C, et al. Role of astrocytes, microglia, and tanycytes in brain control of systemic metabolism. Nat Neurosci. 2019;22(1):7–14. doi: 10.1038/s41593-018-0286-y. [DOI] [PubMed] [Google Scholar]
- 16.Parsons MP, Hirasawa M. ATP-sensitive potassium channel-mediated lactate effect on orexin neurons: implications for brain energetics during arousal. J Neurosci. 2010;30(24):8061–8070. doi: 10.1523/JNEUROSCI.5741-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Lam TK, et al. Regulation of blood glucose by hypothalamic pyruvate metabolism. Science. 2005;309(5736):943–947. doi: 10.1126/science.1112085. [DOI] [PubMed] [Google Scholar]
- 18.Sanders NM, et al. Third ventricular alloxan reversibly impairs glucose counterregulatory responses. Diabetes. 2004;53(5):1230–1236. doi: 10.2337/diabetes.53.5.1230. [DOI] [PubMed] [Google Scholar]
- 19.Elizondo-Vega R, et al. The role of tanycytes in hypothalamic glucosensing. J Cell Mol Med. 2015;19(7):1471–1482. doi: 10.1111/jcmm.12590. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Frayling C, et al. ATP-mediated glucosensing by hypothalamic tanycytes. J Physiol. 2011;589(Pt 9):2275–2286. doi: 10.1113/jphysiol.2010.202051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Cortes-Campos C, et al. MCT expression and lactate influx/efflux in tanycytes involved in glia-neuron metabolic interaction. PLoS One. 2011;6(1):e16411. doi: 10.1371/journal.pone.0016411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Nilaweera K, et al. Photoperiodic regulation of glycogen metabolism, glycolysis, and glutamine synthesis in tanycytes of the Siberian hamster suggests novel roles of tanycytes in hypothalamic function. Glia. 2011;59(11):1695–1705. doi: 10.1002/glia.21216. [DOI] [PubMed] [Google Scholar]
- 23.Pellerin L, Magistretti PJ. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A. 1994;91(22):10625–10629. doi: 10.1073/pnas.91.22.10625. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Clasadonte J, et al. Connexin 43-mediated astroglial metabolic networks contribute to the regulation of the sleep-wake cycle. Neuron. 2017;95(6):1365–1380. doi: 10.1016/j.neuron.2017.08.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Balland E, et al. Hypothalamic tanycytes are an ERK-gated conduit for leptin into the brain. Cell Metab. 2014;19(2):293–301. doi: 10.1016/j.cmet.2013.12.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Prevot V, et al. Activation of erbB-1 signaling in tanycytes of the median eminence stimulates transforming growth factor beta1 release via prostaglandin E2 production and induces cell plasticity. J Neurosci. 2003;23(33):10622–10632. doi: 10.1523/JNEUROSCI.23-33-10622.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Muller-Fielitz H, et al. Tanycytes control the hormonal output of the hypothalamic-pituitary-thyroid axis. Nat Commun. 2017;8(1):484. doi: 10.1038/s41467-017-00604-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Rouach N, et al. Astroglial metabolic networks sustain hippocampal synaptic transmission. Science. 2008;322(5907):1551–1555. doi: 10.1126/science.1164022. [DOI] [PubMed] [Google Scholar]
- 29.Szilvasy-Szabo A, et al. Localization of connexin 43 gap junctions and hemichannels in tanycytes of adult mice. Brain Res. 2017;1673:64–71. doi: 10.1016/j.brainres.2017.08.010. [DOI] [PubMed] [Google Scholar]
- 30.Recabal A, et al. Connexin-43 gap junctions are responsible for the hypothalamic tanycyte-coupled network. Front Cell Neurosci. 2018;12:406. doi: 10.3389/fncel.2018.00406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Martinez F, et al. The median eminence as the hypothalamic area involved in rapid transfer of glucose to the brain: functional and cellular mechanisms. J Mol Med (Berl) 2019;97(8):1085–1097. doi: 10.1007/s00109-019-01799-5. [DOI] [PubMed] [Google Scholar]
- 32.Parkash J, et al. Semaphorin7A regulates neuroglial plasticity in the adult hypothalamic median eminence. Nat Commun. 2015;6:6385. doi: 10.1038/ncomms7385. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Duquenne M, et al. Leptin brain entry via a tanycytic LepR:EGFR shuttle controls lipid metabolism and pancreas function. Nat Metab. 2021;8(8):13–22. doi: 10.1038/s42255-021-00432-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Steffens AB, et al. Penetration of peripheral glucose and insulin into cerebrospinal fluid in rats. Am J Physiol. 1988;255(2 Pt 2):R200–204. doi: 10.1152/ajpregu.1988.255.2.R200. [DOI] [PubMed] [Google Scholar]
- 35.Lam CK, et al. Central lactate metabolism regulates food intake. Am J Physiol Endocrinol Metab. 2008;295(2):E491–E496. doi: 10.1152/ajpendo.90481.2008. [DOI] [PubMed] [Google Scholar]
- 36.Cha SH, Lane MD. Central lactate metabolism suppresses food intake via the hypothalamic AMP kinase/malonyl-CoA signaling pathway. Biochem Biophys Res Commun. 2009;386(1):212–216. doi: 10.1016/j.bbrc.2009.06.017. [DOI] [PubMed] [Google Scholar]
- 37.Lee YS, et al. A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab. 2006;3(2):135–140. doi: 10.1016/j.cmet.2006.01.006. [DOI] [PubMed] [Google Scholar]
- 38.Denis RG, et al. Central orchestration of peripheral nutrient partitioning and substrate utilization: implications for the metabolic syndrome. Diabetes Metab. 2014;40(3):191–197. doi: 10.1016/j.diabet.2013.11.002. [DOI] [PubMed] [Google Scholar]
- 39.Krashes MJ, et al. Melanocortin-4 receptor-regulated energy homeostasis. Nat Neurosci. 2016;19(2):206–219. doi: 10.1038/nn.4202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Gautron L, et al. Neural control of energy balance: translating circuits to therapies. Cell. 2015;161(1):133–145. doi: 10.1016/j.cell.2015.02.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Lelliott C, Vidal-Puig AJ. Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation. Int J Obes Relat Metab Disord. 2004;28(Suppl 4):S22–S28. doi: 10.1038/sj.ijo.0802854. [DOI] [PubMed] [Google Scholar]
- 42.Mayer J. Glucostatic mechanism of regulation of food intake. N Engl J Med. 1953;249(1):13–16. doi: 10.1056/NEJM195307022490104. [DOI] [PubMed] [Google Scholar]
- 43.Oomura Y, et al. Reciprocal activities of the ventromedial and lateral hypothalamic areas of cats. Science. 1964;143(3605):484–485. doi: 10.1126/science.143.3605.484. [DOI] [PubMed] [Google Scholar]
- 44.Machler P, et al. In vivo evidence for a lactate gradient from astrocytes to neurons. Cell Metab. 2016;23(1):94–102. doi: 10.1016/j.cmet.2015.10.010. [DOI] [PubMed] [Google Scholar]
- 45.Leen WG, et al. Cerebrospinal fluid analysis in the workup of GLUT1 deficiency syndrome: a systematic review. JAMA Neurol. 2013;70(11):1440–1444. doi: 10.1001/jamaneurol.2013.3090. [DOI] [PubMed] [Google Scholar]
- 46.Garcia-Caceres C, et al. Astrocytic insulin signaling couples brain glucose uptake with nutrient availability. Cell. 2016;166(4):867–880. doi: 10.1016/j.cell.2016.07.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Gruber T, et al. Obesity-associated hyperleptinemia alters the gliovascular interface of the hypothalamus to promote hypertension. Cell Metab. 2021;33(6):1155–1170. doi: 10.1016/j.cmet.2021.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Guillebaud F, et al. Glial endozepines reverse high-fat diet-induced obesity by enhancing hypothalamic response to peripheral leptin. Mol Neurobiol. 2020;57(8):3307–3333. doi: 10.1007/s12035-020-01944-z. [DOI] [PubMed] [Google Scholar]
- 49.Nuzzaci D, et al. Postprandial hyperglycemia stimulates neuroglial plasticity in hypothalamic POMC neurons after a balanced meal. Cell Rep. 2020;30(9):3067–3078. doi: 10.1016/j.celrep.2020.02.029. [DOI] [PubMed] [Google Scholar]
- 50.Guillebaud F, et al. Blockade of glial connexin 43 hemichannels reduces food intake. Cells. 2020;9(11):2387. doi: 10.3390/cells9112387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Kotini M, et al. Gap junction protein Connexin-43 is a direct transcriptional regulator of N-cadherin in vivo. Nat Commun. 2018;9(1):3846. doi: 10.1038/s41467-018-06368-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Yaswen L, et al. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med. 1999;5(9):1066–1070. doi: 10.1038/12506. [DOI] [PubMed] [Google Scholar]
- 53.Challis BG, et al. Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36) Proc Natl Acad Sci U S A. 2004;101(13):4695–4700. doi: 10.1073/pnas.0306931101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Huszar D, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 1997;88(1):131–141. doi: 10.1016/S0092-8674(00)81865-6. [DOI] [PubMed] [Google Scholar]
- 55.Zheng H, et al. Brain stem melanocortinergic modulation of meal size and identification of hypothalamic POMC projections. Am J Physiol Regul Integr Comp Physiol. 2005;289(1):R247–R258. doi: 10.1152/ajpregu.00869.2004. [DOI] [PubMed] [Google Scholar]
- 56.Zhan C, et al. Acute and long-term suppression of feeding behavior by POMC neurons in the brainstem and hypothalamus, respectively. J Neurosci. 2013;33(8):3624–3632. doi: 10.1523/JNEUROSCI.2742-12.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Cortes-Campos C, et al. MCT2 expression and lactate influx in anorexigenic and orexigenic neurons of the arcuate nucleus. PLoS One. 2013;8(4):e62532. doi: 10.1371/journal.pone.0062532. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Quinones M, et al. Sirt3 in POMC neurons controls energy balance in a sex- and diet-dependent manner. Redox Biol. 2021;41:101945. doi: 10.1016/j.redox.2021.101945. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Al-Massadi O, et al. MCH regulates SIRT1/FoxO1 and reduces POMC neuronal activity to induce hyperphagia, adiposity, and glucose intolerance. Diabetes. 2019;68(12):2210–2222. doi: 10.2337/db19-0029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Messina A, et al. A microRNA switch regulates the rise in hypothalamic GnRH production before puberty. Nat Neurosci. 2016;19(6):835–844. doi: 10.1038/nn.4298. [DOI] [PubMed] [Google Scholar]
- 61.Tschop MH, et al. A guide to analysis of mouse energy metabolism. Nat Methods. 2012;9(1):57–63. doi: 10.1038/nmeth.1806. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Denis RG, et al. Palatability can drive feeding independent of AgRP neurons. Cell Metab. 2015;22(4):646–657. doi: 10.1016/j.cmet.2015.07.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.